%PDF-1.4
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2017-10-16T15:38:26+05:30
2017-10-16T15:38:26+05:30
2017-10-16T15:38:26+05:30
Adobe InDesign CS6 (Macintosh)
uuid:d401fdca-38a7-df47-87f6-f901926b9a45
xmp.did:01801174072068118DBB881A9EDFAAFA
xmp.id:0780117407206811822AAA8E3ACE1529
proof:pdf
converted
from application/x-indesign to application/pdf
Adobe InDesign CS6 (Macintosh)
/
2017-10-16T15:38:26+05:30
xmp.iid:0380117407206811822AAA8E3ACE1529
xmp.did:01801174072068118DBB881A9EDFAAFA
xmp.did:01801174072068118DBB881A9EDFAAFA
default
application/pdf
Adobe PDF Library 10.0.1
False
endstream
endobj
5 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[9.0 9.0 621.0 801.0]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[9.0 9.0 621.0 801.0]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[9.0 9.0 621.0 801.0]/Type/Page>>
endobj
27 0 obj
<>stream
q
/GS0 gs
/Fm0 Do
Q
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
11 0 0 11 45 51.6404 Tm
(52)Tj
ET
q
0 g
/GS0 gs
/Fm1 Do
Q
BT
/TT0 1 Tf
0.02 Tc 0.069 Tw 11 0 0 11 45 697.9917 Tm
[(lacks assay sensitivity to detect a dif)18.2(ference. )55.2(As a)19.9( )]TJ
0.23 Tw 0 -1.182 TD
[(result, without demonstrating assay sensitivity)74.2(, a)19.8( )]TJ
0.01 Tw T*
(non-)Tj
/Span<>> BDC
( )Tj
EMC
2.081 0 Td
(inferiority trial might lead to an erroneous con)Tj
0 Tc 0 Tw (-)Tj
/C2_0 1 Tf
0.02 Tc -0.02 Tw -2.081 -1.182 Td
[<0046004F00580056004C0052005100030052004900030048004900BF004600440046005C>74.2<0011>]TJ
/TT0 1 Tf
0 Tc -0.009 Tw 1.636 -1.773 Td
[(In order to have assay sensitivity)73.8(, a non-inferiority )]TJ
-0.033 Tw -1.636 -1.182 Td
[(trial must be designed )-0.7(the same \(or very similar to\) as )]TJ
0.063 Tw T*
[(the past trials which )-0.7(demonstrated the active control )]TJ
/C2_0 1 Tf
0 Tw T*
[<0048004900BF004600440046005C0003>-23.5<005700520003>-23.4<0048005100560058005500480003>-24.1<0057004B00480003>-23.5<00460052005100560057004400510046005C0003>-23.8<0044005600560058005000530057004C005200510003>-24.2<004C00560003>-23.6<00590044004F004C004700110003>]TJ
/TT0 1 Tf
0.166 Tw 0 -1.182 TD
[(In addition, )-0.7(assay sensitivity also depends )-0.9(on non-)]TJ
/Span<>> BDC
( )Tj
EMC
-0.048 Tw 0 -1.182 TD
[(inferiority margin, and very often an investigator )-0.7(tends )]TJ
0.062 Tw T*
[(to )0.6(specify )0.6(a larger margin to )0.5(reduce the sample size )]TJ
0 Tw T*
[(of a trial, which may reduce or eliminate )-0.9(assay sensi)]TJ
(-)Tj
/C2_0 1 Tf
T*
[<0057004C0059004C0057005C>74.2<00110003>21.4<000B00330052005A0048005500120056004400500053004F00480003>20.2<0056004C005D00480003>20.8<00460044004F00460058004F00440057004C005200510003>20.1<004C00560003>21<0056005300480046004C00BF00460003>20.7<005700520003>21.2<0057004B00480003>]TJ
/TT0 1 Tf
T*
[(type of )0.5(outcome of )0.5(interest, and will not be discussed )]TJ
0 -1.182 TD
(in this article.\) )Tj
0.063 Tw 1.636 -1.773 Td
[(In summary)73.9(, a non-inferiority )-1(trial is typically )-0.6(less )]TJ
0.173 Tw -1.636 -1.182 Td
[(reliable than a superiority)-0.8( )0.6(trial, )0.5(and has to )0.6(be con)]TJ
0 Tw (-)Tj
0.087 Tw 0 -1.182 TD
(ducted with caution due to its inherent weaknesses, )Tj
0.403 Tw T*
[(including )-0.8(arbitrariness in specifying non-inferiority )]TJ
/C2_0 1 Tf
0 Tw 0 -1.182 TD
[<005000440055004A004C0051000F0003>-133.4<005300520057004800510057004C0044004F004F005C0003>-133.5<004C005100590044004F004C00470003>-133.9<0044005600560058005000530057004C005200510056000F0003>-133.5<0044005100470003>-133.4<0047004C004900BF00460058004F>]TJ
/TT0 1 Tf
(-)Tj
0 -1.182 TD
(ties in controlling biases.)Tj
ET
0 0 0 1 K
q 1 0 0 1 327 705.5 cm
0 0 m
258 0 l
S
Q
q 1 0 0 1 327 624.5 cm
0 0 m
258 0 l
S
Q
BT
/TT1 1 Tf
10.25 0 0 10.25 327 687 Tm
(From:)Tj
/TT0 1 Tf
10.5 0 0 10.5 356.0383 687 Tm
[( )18.2(The Department of Pathology \(Y)73.4(ang\) and )]TJ
-2.766 -1.19 Td
[(Internal Medicine \(Berdine\) at )16.6(T)111(exas )17.9(T)111(ech University )]TJ
0 -1.19 TD
[(Health Sciences Center)53.8(, Lubbock, )18(TX)]TJ
/TT1 1 Tf
10.25 0 0 10.25 327 649.5 Tm
(Submitted:)Tj
10.5 0 0 10.5 380.5222 649.5 Tm
( )Tj
/TT0 1 Tf
(10/4/2017)Tj
/C2_1 1 Tf
10.25 0 0 10.25 327 637 Tm
<00260052005100C0004C0046005700560003005200490003004C0051005700480055004800560057001D>Tj
/TT0 1 Tf
10.5 0 0 10.5 426.6572 637 Tm
( none)Tj
ET
q
0 0 630 810 re
W n
BT
/T1_1 1 Tf
13 0 0 13 327 594 Tm
(R)Tj
9.1 0 0 9.1 335.6709 594 Tm
(EFE)Tj
/Span<>> BDC
(R)Tj
EMC
(ENCES)Tj
ET
Q
BT
/T1_0 1 Tf
-0.03 Tc 0.03 Tw 10 0 0 10 327 569 Tm
[(1)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.18 Tw 1.5 0 Td
[(Pui CH, Ev)24.9(ans )29.5(WE. )54.7(A 50-y)19.7(ear jour)-19.8(ne)14.9(y to cure childhood )]TJ
0.286 Tw 0 -1.2 TD
[(acute l)24.9(ymphob)19.8(lastic leuk)9.8(emia. Semin Hematol 2013 Jul; )]TJ
0 Tw T*
(50\(3\):185\226196. )Tj
/T1_0 1 Tf
-0.03 Tc 0.03 Tw -1.5 -1.2 Td
[(2)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.444 Tw 1.5 0 Td
[(F)49.8(ood and Dr)-19.8(ug )54.9(Administration. Non-inferiority clinical )]TJ
0.076 Tw /Span<>> BDC
T*
( )Tj
EMC
0 0 TD
[(trials to estab)19.8(lish ef)24.9(fecti)25(v)14.8(eness: guidance for industr)-19.8(y 2016. )]TJ
0 Tw 0 -1.2 TD
(Accessed Oct. 6, 2017.)Tj
/T1_0 1 Tf
-0.03 Tc 0.03 Tw -1.5 -1.2 Td
[(3)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.016 Tw 1.5 0 Td
[(Kaul S, Diamond GA. Good enough: )54.9(A primer on the anal)25(y)]TJ
0 Tw (-)Tj
0.003 Tw T*
[(sis and inter)-29.7(pretation of noninferiority trials. )55.2(Annals Int Med )]TJ
0 Tw T*
(2006;145:62\22669.)Tj
/T1_0 1 Tf
-0.03 Tc 0.03 Tw -1.5 -1.2 Td
[(4)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc -0.029 Tw 1.5 0 Td
[(Hahn S. Understanding noninferiority trials. K)34.9(orean J P)39.8(ediatr )]TJ
0 Tw T*
(2012;55\(11\):403\2267. )Tj
/T1_0 1 Tf
-0.03 Tc 0.03 Tw -1.5 -1.2 Td
[(5)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc -0.025 Tw 1.5 0 Td
[(Snapinn SM. Noninferiority trials. Cur)-29.7(r Control )49.4(T)34.9(rials Cardi)]TJ
0 Tw (-)Tj
T*
[(o)44.9(v)24.9(asc Med 2000;1\(1\):19\22621.)]TJ
ET
endstream
endobj
22 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
BT
0 0 0 1 k
/GS0 gs
/T1_0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 8 0 0 8 282.3892 54.1778 Tm
(The Southwest Respiratory and Critical Care Chronicles 2017;5\(21\):50\226\
52)Tj
ET
endstream
endobj
31 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
0 0 0 1 K
0.5 w 4 M 0 j 0 J
/GS0 gs
q 1 0 0 1 45 68.8957 cm
0 0 m
540 0 l
S
Q
10 M
q 1 0 0 1 45 740.2762 cm
0 0 m
540 0 l
S
Q
BT
0 0 0 1 k
/TT0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 8 0 0 8 45 751.5262 Tm
[(Y)74.2(ang et al.)]TJ
/Span<>> BDC
( )Tj
EMC
58.572 0 Td
[(Non-Inferiority T)73.8(rials)]TJ
ET
endstream
endobj
33 0 obj
<>
endobj
34 0 obj
<>
endobj
35 0 obj
<>stream
H\j0\/Jm
!0r t1NzdfHïn[\8O7.xJR0^cTDvO,!tA?+<}h`Ot 6ònIW:4ή;{EU4*(4*']zyU\GxLXS k$0L8c΅sB`mp,g|V~GENx,)>IMk}l
GT_ j.
endstream
endobj
36 0 obj
<>stream
HlU TUGAYp|1*T$A3.,*ƸQ"h+7>1b2$3㜤y_uo}Xuvs1 Ǵ$c
@Z`dBTl#Vy9fpy8~zɀɉDѱI)1'x=O[pw>
OIC
W c\xlkr2!>1Iokuа0'"aUѼ$WRU끶Ԫ* R4ԄA !
5FŃ`|-k b +wTocO~OxoJ,,ޱnξc-]ZnӶԾ{GNzvҵ[w={ׯ_
2tF8:1c}2~{IcQ3fΊO='1in-xK-[Ɋ>]fm6c>߲mwܕ=__`aQG;^r?O}ss.W|[ye\znܼu{
g:SwGByqA7:]m&q1n&dor15yLSLnOk
uN349~nNFc>^z>Q_-PMijlYV3Ʈzfuj檬U+UVuSgW6x[5}fH%z/Idc6>A:Vc vO`->J|j oXE\XGxjEn>qQ"R
9W;ƙ <7<3=s@<`DoF Nb
c+)11Z;b8X P%qH)RX#XC8ףLh8űR[qU-R%^a+FRrh_@8Y%m^
W89똍rZ'"\#˴}η'K.fDw+!:EIe_9yG J,f,+Z4Ћ86H"Fl
D\c>c~l^/rU%=9u VI#Bj҃Gfby_Vg*@GkCG)cdapjs#ZLm\1]5s &?GZGt.U1Q,Q)P;GA
U*Q]5ۼ\`/z=َ1wcD!3 +i={؎131_9RK@ȋ
(JTZJA[(P!GSJg=aIt^QbX]-qWԊg╴l&.H&eL^ƳB(UZr~uI^iZQ\j
0
цM#bEBEK-Y²e>:
8ӷc^RTQt{)Xd#0K~AWQX%4ZR2%C7J"OvF)ʖ&=U%C䉺{j7ߖ=/[w"0u`%2.ЋF4F<~{Ƚ'%]4_>M0E5iI4a YAYy%̗Q-Te#"
*JNɓhT!#8nd2Vm"Zd4G"Q(5H7U
F}XDǐG(.32Eʙu;^}&wOm}%RԜl%"Ǯq>%cvRC))PKQmҒs*&3L:_!'0x40?x{?<{}{o+Y %J$Ɣ[(a@ɐ`(ZǐJZS-ij+X2(ӒdU*^ &Ӥ٘8e^%)kGl更za[KM@ځ2$o&AٮIN)Y#R&-ް,Z9HfUS\Ht;4OWE4XRCPy`Gu{
C&+JÌ
Jd?*i[(`KOSIpOa%KGJG$CP)#$h1B(M-B+V
5uH}bP%-Iѳ]#GI۽')40CxW`#i360XCQC)b%**1+X=RpQcDI+ ePUcz||jZUVD :ʃY+ 2ꩪ1&KT)Q~L,KVK
%V7[leG?K=J_@^}{WqK+ezL(fL)degfPB*#XbiR[iT]CYMK]?_Cga6Fm,)ruqbPDE"li9ūFt61Zh[CA<1IOq+Ԇ<鸀,l^beVB1̵*gevgP747#IfA J!5%M'9|߂ϣ ;-l;g3(9qCHܧ~s1e5!Z9:Cq۸BN:y`.(:=^(Dn:f#q ?9w:Gh!@ ,:p|"?_C, 8 ;!Q2.!I (ČJi
h!Ȁ HE7%tBm/ЙfaRrƜBYyz5@+rq."f_cq<3ۯX[KXxWnzksAy֏nkE8+?Z:L$>0cH"Cq' ȞFLܔ2Sȱ&J
P3SJg0A$~dLфdu2Qevvbe,1=v/4*ʂp{L|98aF Ύv(]pv"W2(`#W0u9flChE C3
]>4K
p=SV
A[!螼+}fpZ_1}t0_Y{_瞛 r`ol
MZ3-8jG4хw`.i>-?+z;ǜE#J\e|N[[( я}!>fkkd7T{Z$)q[)DYho
E#LgKČAK/Eu8Ky/T\hH_-{46tsGzSj]Liut{-ly+1.R_ޖN3 ΥW[ǞNx!||Mû-}yhyWީN:\kwlnn.gt 7ol_~@
vK=o Ɵ MO!y\TMC˓xө >"<w`P%"!xǽ5PO]@x%<{ZNƔ[K)c?YV}{ 3Yߧ Q)90mS[ 8śe>g_=yxim܋׳foq^N℥e %ȼ@)]!P
1KSJ+]
QI-E$tU*Rm&NƪuX;'4-J9D~o߾PZ#zm7=sՕs{8Qow4ÓNa'yGA]~u uDSg\t3 -&U &d(Fґ[)[ᣌk|<gj!iI!\ _ymE!watF]-9Nd2Ŷ(fof>졍 =*6_6oeqN{;ȾN3,cTjPu'⭚thDTǥH5JMq֡5fECD4)/@,zUri+fEBD$*jI T\Qq=BL
L}<*9OU
}`Fﳼmпgb2 2Q
+RM;p+~QKpC¢(<